3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
6
Advanced Solid Tumors
5
Advanced Solid Tumour
4
Small Cell Lung Carcinoma
3
Recurrence
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumor
2
Unresectable Locally Recurrent Breast Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Non-small Lung Cancer
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Sclerosis
1
Metastatic Solid Tumors
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Interventions
Whole-Body Irradiation
5
Cyclophosphamide
5
fludarabine phosphate
4
Busulfan
4
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclosporine
3
venetoclax
2
fludarabine
2
Tacrolimus
2
Specimen Handling
2
Methotrexate
2
Etoposide
2
Biopsy
2
Azacitidine
2
Antilymphocyte Serum
2
merphos
1
ivosidenib
1
decitabine and cedazuridine drug combination
1
Vorinostat
1
Thiotepa
1
TAK-243
1
Sirolimus
1
Rituximab
1
Lenalidomide
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
Injections
×
30 days
×
Clear all
No trials found.